Theodore Ashburn
Nessuna posizione attualmente
Patrimonio netto: 12 518 $ in data 31/12/2023
Profilo
Founder of Dynogen Pharmaceuticals, Inc. and BrainCells, Inc., Theodore T.
Ashburn is former Chairman at Oncorus, Inc., former Head-Oncology Development at Moderna, Inc., former Global Head-Product at Sanofi Oncology, former Head-Global Product at Leukine, former Senior VP-Operations & Product Strategy at Dicerna Pharmaceuticals, Inc. and former Senior Director-Business Development at Dynogen Pharmaceuticals, Inc.
He received a doctorate from Massachusetts Institute of Technology, an undergraduate degree from Ball State University (Indiana) and a doctorate from Harvard Medical School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ONCORUS, INC.
0.38% | 31/03/2023 | 99 352 ( 0.38% ) | 12 518 $ | 31/12/2023 |
Precedenti posizioni note di Theodore Ashburn
Società | Posizione | Fine |
---|---|---|
ONCORUS, INC. | Chief Executive Officer | 06/06/2023 |
MODERNA, INC. | Corporate Officer/Principal | 01/07/2018 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Founder | 13/11/2009 |
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Corporate Officer/Principal | - |
Leukine | Corporate Officer/Principal | - |
Formazione di Theodore Ashburn
Ball State University (Indiana) | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ONCORUS, INC. | Health Technology |
MODERNA, INC. | Health Technology |
Aziende private | 5 |
---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Commercial Services |
Leukine |